Thrombotic	thrombotic	O	B_disease
microangiopathy	microangiopathy	O	S_disease
and	and	O	O
renal	renal	O	B_disease
failure	failure	O	I_disease
associated	associated	O	O
with	with	O	O
antineoplastic	antineoplastic	S_chemicals	O
chemotherapy	chemotherapy	O	O
.	.	O	O

Five	five	O	O
patients	patients	O	O
with	with	O	O
carcinoma	carcinoma	O	S_disease
developed	developed	O	O
thrombotic	thrombotic	O	B_disease
microangiopathy	microangiopathy	O	S_disease
(	(	O	O
characterized	characterized	O	O
by	by	O	O
renal	renal	O	B_disease
insufficiency	insufficiency	O	I_disease
,	,	O	O
microangiopathic	microangiopathic	O	B_disease
hemolytic	hemolytic	O	B_disease
anemia	anemia	O	S_disease
,	,	O	O
and	and	O	O
usually	usually	O	O
thrombocytopenia	thrombocytopenia	O	S_disease
)	)	O	O
after	after	O	O
treatment	treatment	O	O
with	with	O	O
cisplatin	cisplatin	S_chemicals	O
,	,	O	O
bleomycin	bleomycin	S_chemicals	O
,	,	O	O
and	and	O	O
a	a	O	O
vinca	vinca	O	O
alkaloid	alkaloid	S_chemicals	O
.	.	O	O

One	one	O	O
patient	patient	O	O
had	had	O	O
thrombotic	thrombotic	O	B_disease
thrombocytopenic	thrombocytopenic	O	B_disease
purpura	purpura	O	S_disease
,	,	O	O
three	three	O	O
the	the	O	O
hemolytic-uremic	hemolytic-uremic	O	B_disease
syndrome	syndrome	O	S_disease
,	,	O	O
and	and	O	O
one	one	O	O
an	an	O	O
apparent	apparent	O	O
forme	forme	O	B_disease
fruste	fruste	O	I_disease
of	of	O	O
one	one	O	O
of	of	O	O
these	these	O	O
disorders	disorders	O	O
.	.	O	O

Histologic	histologic	O	O
examination	examination	O	O
of	of	O	O
the	the	O	O
renal	renal	O	O
tissue	tissue	O	O
showed	showed	O	O
evidence	evidence	O	O
of	of	O	O
intravascular	intravascular	O	B_disease
coagulation	coagulation	O	I_disease
,	,	O	O
primarily	primarily	O	O
affecting	affecting	O	O
the	the	O	O
small	small	O	O
arteries	arteries	O	O
,	,	O	O
arterioles	arterioles	O	O
,	,	O	O
and	and	O	O
glomeruli	glomeruli	O	O
.	.	O	O

Because	because	O	O
each	each	O	O
patient	patient	O	O
was	was	O	O
tumor-free	tumor-free	O	S_disease
or	or	O	O
had	had	O	O
only	only	O	O
a	a	O	O
small	small	O	O
tumor	tumor	O	S_disease
at	at	O	O
the	the	O	O
onset	onset	O	O
of	of	O	O
this	this	O	O
syndrome	syndrome	O	S_disease
,	,	O	O
the	the	O	O
thrombotic	thrombotic	O	B_disease
microangiopathy	microangiopathy	O	S_disease
may	may	O	O
have	have	O	O
been	been	O	O
induced	induced	O	O
by	by	O	O
chemotherapy	chemotherapy	O	O
.	.	O	O

Diagnosis	diagnosis	O	O
of	of	O	O
this	this	O	O
potentially	potentially	O	O
fatal	fatal	O	O
complication	complication	O	O
may	may	O	O
be	be	O	O
delayed	delayed	O	O
or	or	O	O
missed	missed	O	O
if	if	O	O
renal	renal	O	O
tissue	tissue	O	O
or	or	O	O
the	the	O	O
peripheral	peripheral	O	O
blood	blood	O	O
smear	smear	O	O
is	is	O	O
not	not	O	O
examined	examined	O	O
,	,	O	O
because	because	O	O
renal	renal	O	B_disease
failure	failure	O	I_disease
may	may	O	O
be	be	O	O
ascribed	ascribed	O	O
to	to	O	O
cisplatin	cisplatin	S_chemicals	O
nephrotoxicity	nephrotoxicity	O	O
and	and	O	O
the	the	O	O
anemia	anemia	O	S_disease
and	and	O	O
thrombocytopenia	thrombocytopenia	O	S_disease
to	to	O	O
drug-induced	drug-induced	O	S_disease
bone	bone	O	B_disease
marrow	marrow	O	I_disease
suppression	suppression	O	O
.	.	O	O

